Skip to main content
. 2025 Nov 19;391:e086026. doi: 10.1136/bmj-2025-086026

Fig 6.

Fig 6

Pooled efficacy estimates of multiple comparisons in second line or later line settings based on network meta-analysis. Data are pooled hazard ratios (95% credible intervals) for overall survival and progression-free survival. Bold data indicate statistical significance. BRAF=B-Raf proto-oncogene, serine/threonine kinase; EGFR=epidermal growth factor receptor; MEK=mitogen-activated protein kinase kinase; PI3K=phosphoinositide 3-kinase; VEGF=vascular endothelial growth factor